New Medium to Boost and Optimise the Production of AAV in Sf9 Insect Cells Announced

摘要

Lonza announces the launch of the TheraPEAK~TM SfAAV~TM Medium,the first chemically defined,non-animal origin medium designed specifically for the production of Adeno Associated Virus(AAV)in Spodoptera Fuigiperda(Sf9)insect cells for gene therapy applications.The new high-performance medium accelerates cell growth,increases productivity,and reduces process variability and costs,expediting time-to-market for safe,scalable,life-saving gene therapies.The unique benefits of the TheraPEAK~TM SfAAV~TM Medium,which marks the latest addition to Lonza's TheraPEAK~TM Family of cell culture media and reagents for cell and gene therapy applications,are summarised in an informative poster that can be downloaded for free from the Lonza website.